Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
作者信息
Naggie Susanna, Ramers Christian B
机构信息
Duke University School of Medicine Durham NC.
Duke Clinical Research Institute Durham NC.
出版信息
Hepatol Commun. 2019 Apr 1;3(4):453-455. doi: 10.1002/hep4.1347. eCollection 2019 Apr.
Abstract
摘要
相似文献
1
Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
Hepatol Commun. 2019 Apr 1;3(4):453-455. doi: 10.1002/hep4.1347. eCollection 2019 Apr.
2
Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review.
Int J Infect Dis. 2016 May;46:27-33. doi: 10.1016/j.ijid.2016.03.022. Epub 2016 Mar 29.
3
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy.
J Hepatol. 2019 Jul;71(1):45-51. doi: 10.1016/j.jhep.2019.02.018. Epub 2019 Mar 8.
4
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
CMAJ. 2019 Apr 29;191(17):E462-E468. doi: 10.1503/cmaj.181506.
5
Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.
Am J Prev Med. 2020 Jun;58(6):845-853. doi: 10.1016/j.amepre.2020.01.024.
6
Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.
Ann Intern Med. 2019 May 7;170(9):594-603. doi: 10.7326/M18-1715. Epub 2019 Apr 9.
7
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Addiction. 2021 Mar;116(3):525-535. doi: 10.1111/add.15168. Epub 2020 Jul 14.
8
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
J Hepatol. 2020 Apr;72(4):643-657. doi: 10.1016/j.jhep.2019.11.012. Epub 2019 Nov 27.
9
A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.
J Infect Dis. 2020 Jul 6;222(3):488-498. doi: 10.1093/infdis/jiaa100.
10
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
Clin Infect Dis. 2020 Oct 23;71(7):1715-1722. doi: 10.1093/cid/ciaa105.
引用本文的文献
1
Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.
South Med J. 2022 Jun;115(6):352-357. doi: 10.14423/SMJ.0000000000001402.
2
Hepatitis C virus: A critical approach to who really needs treatment.
World J Hepatol. 2022 Jan 27;14(1):1-44. doi: 10.4254/wjh.v14.i1.1.
本文引用的文献
1
Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy.
Hepatol Commun. 2019 Jan 10;3(4):478-492. doi: 10.1002/hep4.1307. eCollection 2019 Apr.
2
A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015.
EBioMedicine. 2018 Nov;37:374-381. doi: 10.1016/j.ebiom.2018.10.007. Epub 2018 Nov 15.
3
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents.
J Intern Med. 2018 May;283(5):500-507. doi: 10.1111/joim.12740. Epub 2018 Mar 7.
4
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6.
5
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007.
6
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Ann Intern Med. 2016 Nov 1;165(9):625-634. doi: 10.7326/M16-0816. Epub 2016 Aug 9.
7
Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C.
Open Forum Infect Dis. 2014 Dec 13;1(3):ofu110. doi: 10.1093/ofid/ofu110. eCollection 2014 Dec.
8
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.
Clin Infect Dis. 2009 Mar 1;48(5):650-8. doi: 10.1086/596770.
Zotero 插件